Jenene Thomas | Investor Relations |
Walter Klemp | Chairman and Chief Executive Officer |
John Paul Waymack | Senior Chief Medical Officer |
Jonathan Foster | Executive Vice President and Chief Financial Officer |
Jonathan Aschoff | ROTH MKM |
Jeff Jones | Oppenheimer |
Hello and welcome to the Moleculin Biotech Q1 2023 Quarterly Update Conference Call and Webcast. [Operator Instructions] A question-and-answer session will follow the formal presentation.
As a reminder, this conference is being recorded.
It is now my pleasure to turn the call over to your host Jenene Thomas, Investor Relations. Please go ahead, Jenene.